Botanix adds Payer coverage representing ~65 million commercial lives
Ascent Health, the second largest Payer organisation in the US, will now cover Sofdra™ (sofpironium) topical gel, 12.45%. Ascent Health represents approximately 65 million (or nearly 40%) of US commercial lives.
The Ascent coverage adds to the existing Payer coverage and coverage actively being finalised with Payers. The Company will share updates as coverage is announced in coming months, before our Sales Professionals begin calling on dermatologists
https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02880659-6A1237535
DISC: Held in RL & SM